Schering-Plough Corporation
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 16.44 |
| 52 Week High | 33.40 |
| 52 Week Low | 13.83 |
| Avg. Daily Vol. (Mil) | 15.09 |
| Beta (3 year) | 1.46 |
| Share Related Items | |
| Mkt Cap (Mil) | 26,724.73 |
| Shares Out (Mil) | 1,625.59 |
| Float (Mil) | 1,623.64 |
| Dividend Information | |
| Yield % | 1.60 |
| Annual Dividend | 0.26 |
| Payout Ratio | n.a. |
| Financial Strength | |
| Quick Ratio | 1.10 |
| Current Ratio | 2.00 |
| LT Debt/ Equity | 1.02 |
| Total Debt / Equity | 1.07 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.66 |
| Price/Book | 3.02 |
| Price/Cash Flow | 822.00 |
| Per Share Data | |
| Earnings | -1.35 |
| Sales | 9.91 |
| Book Value | 5.45 |
| Cash Flow | 0.02 |
| Business Summary | |
|---|---|
| The Company discovers, develops and manufactures pharmaceuticals for three customer markets - human prescription, animal health, and consumer. | |
| General Information | |
| 2000 Galloping Hill Road
Kenilworth, NJ 07033 |
|
| www.schering-plough.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 55000 | |
| CEO: Fred Hassan | |
| Short Interest | |
| Current Month (Mil) | 26.80 |
| Previous Month (Mil) | 23.61 |
| Short Interest Ratio (Days) | 2.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -6.10 |
| Return on Investments | -9.10 |
| Profitability | |
| Gross Margin | 72.10 |
| EBIT Margin | -7.40 |
| Profit Margin | -11.50 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas